Metraipolis › archive › dc_4ae38bf61cbe

Tumor-Targeted Delivery Therapy Based on PLGA Nanoparticles — Europe PMC PMID:42188374

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42188374
DOI
10.3390/jfb17050207
License (as archived)
solo-consultazione
Archived
2026-11-03T07:27:48.147Z
SHA-256 of the archived text
963d708deee3f5a5d03781215b8c76a09808479a6cf27bbcca66cd6a61c6e1b4
Stable URL of this page
https://metraipolis.com/documento/dc_4ae38bf61cbe

How to cite

Tumor-Targeted Delivery Therapy Based on PLGA Nanoparticles — Europe PMC PMID:42188374 — Europe PMC (en), https://europepmc.org/article/MED/42188374 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4ae38bf61cbe (Metraipolis archive dc_4ae38bf61cbe, sha256 963d708deee3f5a5d03781215b8c76a09808479a6cf27bbcca66cd6a61c6e1b4)
BibTeX
@misc{dc4ae38bf61cbe,
  title = {Tumor-Targeted Delivery Therapy Based on PLGA Nanoparticles — Europe PMC PMID:42188374},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42188374},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4ae38bf61cbe; sha256 963d708deee3f5a5d03781215b8c76a09808479a6cf27bbcca66cd6a61c6e1b4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42188374. Agents can read the archived copy with the MCP tool read_document.